OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Sri Lankan Kidney Foundation

Charity No. 1180650

Company No. CE015589

Trustee's Report and Unaudited Accounts

31 December 2024

Sri Lankan Kidney Foundation Contents

Pages
Trustee's Annual Report 2 to 2
Statement of Financial Activities 3 to 3
Summary Income and Expenditure Account 4 to 4
Balance Sheet 5 to 5
Statement of Cash flows 6 to 6
Notes to the Accounts 7 to 7
Detailed Statement of Financial Activities 8

Page 1

Sri Lankan Kidney Foundation Trustees Annual Report

The trustee, who is also a director of the charity for the purposes of the Companies Act 2006, presents their report with the unaudited financial statements of the charity for the year ended 31 December 2024.

REFERENCE AND ADMINISTRATIVE DETAILS

Company No. CE015589

Charity No. 1180650

Registered Office

2 Montgomery close, Grantham NG31 7GG

Director and Trustee

The Director of the charitable company are its Trustee for the purposes of charity law. The following Director and Trustee served during the year:

C. Perera

Accountants

Grip Business 101 Lockhurst Lane Coventry CV6 5SF

The Trustee is responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustee is also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).

Signed on behalf of the board

C. Perera Trustee 23 October 2025

Page 2

Sri Lankan Kidney Foundation Statement of Financial Activities

for the year ended 31 December 2024

Notes
Income and endowments
from:
Donations and legacies
4
Other
5
Total
Expenditure on:
Raising funds
6
Charitable activities
7
Other
8
Total
Net gains on investments
Net (expenditure)/income
Transfers between funds
Net (expenditure)/income
before other gains/(losses)
Other gains and losses
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
Unrestricted
funds
2024
£
55,642
2,286
Total funds
2024
£
55,642
2,286
Total funds
2023
£
41,369
869
57,928
42,099
19,377
149
57,928
42,099
19,377
149
42,238
26,598
3,314
92
61,625
-
61,625
-
30,004
-
(3,697)
-
(3,697)
-
12,234
-
(3,697) (3,697) 12,234
(3,697)
30,090
(3,697)
30,090
12,234
17,856
26,393 26,393 30,090

Page 3

Sri Lankan Kidney Foundation Summary Income and Expenditure Account

for the year ended 31 December 2024

Income
Gross income for the year
Expenditure
Total expenditure for the year
Net (expenditure)/income before tax
for the year
Net (expenditure )/income for the year
2024
£
57,928
57,928
61,625
61,625
(3,697)
(3,697)
2023
£
42,238
42,238
30,004
30,004
12,234
12,234

Page 4

Sri Lankan Kidney Foundation Balance Sheet

at 31 December 2024

at 31 December 2024
Company No.
CE015589
Notes
2024
£
Current assets
Cash at bank and in hand
26,393
26,393
Net current assets
26,393
Total assets less current liabilities
26,393
Net assets excluding pension asset or liability
26,393
Total net assets
26,393
The funds of the charity
Restricted funds
10
Unrestricted funds
10
General funds
26,393
26,393
Reserves
10
Total funds
26,393
2023
£
30,090
30,090
30,090
30,090
30,090
30,090
30,090
30,090
30,090

These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

For the year ended 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

Approved by the board on 23 October 2025

And signed on its behalf by:

C. Perera Trustee

23 October 2025

Page 5

Sri Lankan Kidney Foundation Statement of Cash flows for the year ended 31 December 2024

Cash flows from operating activities
Net (expenditure)/income per Statement of Financial Activities
Adjustments for:
Dividends, interest and rents from investments
Net cash (used in)/provided by operating activities
Cash flows from investing activities
Dividends, interest and rents from investments
Net cash from investing activities
Net cash from financing activities
Net (decrease)/increase in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Components of cash and cash equivalents
Cash and bank balances
2024
£
(3,697)
(2,286)
(5,983)
2,286
2,286
-
(3,697)
30,090
26,393
26,393
26,393
2023
£
12,234
(869)
11,365
869
869
-
12,234
17,856
30,090
30,090
30,090

Page 6

Sri Lankan Kidney Foundation Notes to the Accounts

for the year ended 31 December 2024

Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Change in basis of accounting or to previous accounts

There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.

Fund accounting

Income

Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets

Page 7

Sri Lankan Kidney Foundation Notes to the Accounts

Expenditure

Taxation

The charity is exempt from corporation tax on its charitable activities.

Freehold investment property

Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.

Stocks

Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.

Trade and other debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.

Trade and other creditors

Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Page 8

Sri Lankan Kidney Foundation Notes to the Accounts

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Foreign currencies

Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period.

Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred.

All exchange differences are are taken into account in arriving at net income/expenditure.

Leased assets

Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.

Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.

Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs.

Assets held under finance leases are depreciated in the same way as owned assets.

Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.

Pension costs

The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

Receipt of donated goods, facilities and services

All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.

2 Company status

The company is a private company limited by guarantee and consequently does not have share capital.

Page 9

Sri Lankan Kidney Foundation Notes to the Accounts

3 Statement of Financial Activities - prior year

3
Statement of Financial Activities - prior year
Income and endowments from:
Donations and legacies
Other
Total
Expenditure on:
Raising funds
Charitable activities
Other
Total
Net income
Net income before other
gains/(losses)
Other gains and losses:
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
4
Income from donations and legacies
5
Other income
Unrestricted
£
55,642
55,642
Unrestricted
£
2,286
2,286
Unrestricted
funds
2023
£
41,369
869
42,238
26,598
3,314
92
30,004
12,234
12,234
12,234
17,856
30,090
Total
2024
£
55,642
55,642
Total
2024
£
2,286
2,286
Total funds
2023
£
41,369
869
42,238
26,598
3,314
92
30,004
12,234
12,234
12,234
17,856
30,090
Total
2023
£
41,369
41,369
Total
2023
£
869
869

Page 10

Sri Lankan Kidney Foundation Notes to the Accounts

6 Expenditure on raising funds

Costs of generating voluntary
income
7
Expenditure on charitable activities
Expenditure on charitable
activities
Governance costs
8
Other expenditure
General administrative costs
9
Staff costs
No employee received emoluments in excess
10 Movement in funds
Restricted funds:
Unrestricted funds:
General funds
Total funds
of £60,000.
At 1 January
2024
30,090
30,090
Unrestricted
£
42,099
42,099
Unrestricted
£
19,377
19,377
Unrestricted
£
149
149
Incoming
resources
(including
other
gains/losses
)
£
57,928
57,928
Total
2024
£
42,099
42,099
Total
2024
£
19,377
19,377
Total
2024
£
149
149
Resources
expended
£
(61,625)
(61,625)
Total
2023
£
26,598
26,598
Total
2023
£
3,314
3,314
Total
2023
£
92
92
At 31
December
2024
£
26,393
26,393

Page 11

Sri Lankan Kidney Foundation Notes to the Accounts

11 Analysis of net assets between funds

11 Analysis of net assets between funds
Net current assets
12 Reconciliation of net debt
Cash and cash equivalents
Net debt
At 1 January
2024
£
Unrestricted
funds
£
26,393
26,393
Cash flows
£
Total
£
26,393
26,393
At 31
December
2024
£
30,090 (3,697) 26,393
30,090
30,090
(3,697)
(3,697)
26,393
26,393

13 Related party disclosures Controlling party

The company is limited by guarantee and has no share capital; thus no single party controls the company.

Page 12

Sri Lankan Kidney Foundation Detailed Statement of Financial Activities

for the year ended 31 December 2024

Income and endowments from:
Donations and legacies
Other
Total income and endowments
Expenditure on:
Costs of generating donations and
legacies
Total of expenditure on raising
funds
Charitable activities
Total of expenditure on charitable
activities
General administrative costs,
including depreciation and
amortisation
Bank charges
Sundry expenses
Total of expenditure of other costs
Total expenditure
Net gains on investments
Net (expenditure)/income
Net (expenditure)/income before
other gains/(losses)
Other Gains
Net movement in funds
Reconciliation of funds:
Unrestricted
funds
2024
£
55,642
55,642
2,286
2,286
57,928
42,099
42,099
42,099
19,377
19,377
19,377
66
83
149
149
61,625
-
(3,697)
(3,697)
-
(3,697)
Total funds
2024
£
55,642
55,642
2,286
2,286
57,928
42,099
42,099
42,099
19,377
19,377
19,377
66
83
149
149
61,625
-
(3,697)
(3,697)
-
(3,697)
Total funds
2023
£
41,369
41,369
869
869
42,238
26,598
26,598
26,598
3,314
3,314
3,314
36
56
92
92
30,004
-
12,234
12,234
-
12,234

Page 13

Sri Lankan Kidney Foundation Detailed Statement of Financial Activities

Sri Lankan Kidney Foundation
Detailed Statement of Financial Activities
Total funds brought forward
Total funds carried forward
30,090
26,393
30,090
26,393
17,856
30,090

Page 14

Independent examiner's report on the accounts

Section A Independent Examiner’s Report

Report to the trustees/ Charity Name members of Sri Lankan Kidney Foundation

On accounts for the year 31/12/2024 Charity no ended (if any) 1180650 Set out on pages 3 to 12 pages

I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31 / 12 / 2024.

Responsibilities and As the charity's trustees, you are responsible for the preparation of the basis of report accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent [The charity’s gross income exceeded £25,000 and I am qualified to examiner's statement undertake the examination by being a qualified member of Chartered Institute of Management Accountants (CIMA)

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination (other than that disclosed below *) which gives me cause to believe that in, any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Signed: Date: 21/10/2025 Name: Harisuthan Sharma Ganeswaran

Relevant professional Chartered Institute of Management Accountants (CIMA) qualification(s) or body

Oct 2018

IER

16

(if any):

Address: 101 Lockhurst Lane

Coventry CV6 5SF

Section B Disclosure

Only complete if the examiner needs to highlight material matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners).

Give here brief details of any items that the The charity has been advised to keep their records on an accounting package examiner wishes to to make the examination process in more reliable in the coming years. disclose .

17

Oct 2018

IER